Becton, Dickinson and Company BDX, popularly known as BD, announced that the FDA granted 510(k) clearance for its novel blood collection device, MiniDraw. This revolutionary device is likely to ...

Add Yahoo as a preferred source to see more of our stories on Google. Getty Images; Alyssa Powell/BI Needle-free devices like TAP and Tasso offer painless blood collection, a benefit for the squeamish ...

Becton, Dickinson (NYSE:BDX) on Thursday announced that its novel blood collection device has received 510(k) clearances from the U.S. Federal Drug Administration. BD MiniDraw Capillary Blood ...

Theranos had a lot of bad ideas, but making blood draws smaller and easier wasn’t necessarily one of them. A decade after the now-defunct blood-testing startup emerged from stealth, BD has now claimed ...

BD’s new MiniDraw diagnostic devices could let pharmacists—and, one day, maybe patients—manage blood testing needs and monitor health conditions. BD received its FDA authorizations for two blood draw ...

BD MiniDraw™ Capillary Blood Collection System Enables Lab-Quality Blood Testing from Less Invasive Method than Venous Collection in More Convenient Locations FRANKLIN LAKES, N.J., Dec. 7, 2023 ...

Please provide your email address to receive an email when new articles are posted on . The BD MiniDraw device is part of a blood testing collection system that is designed to make routine blood tests ...

BD is building on its goal of providing patients with a “one-stick hospital stay” with a new FDA clearance for painless blood collection hardware that works through already placed IV lines. The ...

(RTTNews) - Medical technology company Becton, Dickinson and Co. or BD (BDX) announced Thursday it has received 510(k) clearances from the U.S. Federal Drug Administration (FDA) for a novel blood ...